Piramal Pharma Moves to Acquire Full Ownership of Yapan Bio
Piramal Pharma has initiated discussions with Yapan Bio’s existing shareholders to finalise the acquisition, which will give it full ownership of the CDMO specialising in vaccine and biologics manufacturing.
Proposed Acquisition | 20/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy